39 completed, 14 unknown, 7 terminated, 6 recruiting. 69 Phase 2, 14 Phase 3, 10 Phase 1.
Follow Pentoxifylline: new trials by email Literature Review of Pentoxifylline trials Research Report on Pentoxifylline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation Pentoxifylline, Placebo, α-Tocopherol - Non-Small Cell Lung Cancer, Radiation Induced Lung Injury (RILI) | Phase 2 | Recruiting | University Health Network, Toronto | 150 | 2026-06-15 | 2026-08-06 |
| Pentoxifylline in Patients With Ulcerative Colitis Mesalamine, Pentoxifylline - Inflammatory Bowel Diseases | Phase 2 | Recruiting | Ihab Elsayed Hassan | 60 | 2026-01-20 | 2026-04-15 |
| Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients Pentoxifylline 400mg plus chemotherapy - Doxorubicin Induced Cardiotoxicity, Breast Cancer | Phase 2 | Completed | Tanta University | 46 | 2025-09-01 | 2026-09-30 |
| Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose) Pravastatin (drug), Pentoxifylline, ketoprofen - Fibrosis Syndrome, Lymphedema | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 250 | 2025-08-08 | 2026-07-24 |
| Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis Methotrexate, Pentoxifylline - Rheumatoid Arthritis | Phase 2 | Recruiting | Tanta University | 50 | 2025-06-02 | 2026-10-05 |
| Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice Pentoxifylline - Hepatobiliary Disorders | Phase 2 | Completed | Tanta University | 45 | 2025-04-30 | 2026-09-30 |
| Pentoxifylline for Vascular Calcification in Kidney Disease Pentoxifylline 400 MG Oral Tablet, Conventional Medications for Chronic Kidney Disease - Chronic Kidney Disease, Vascular Calcification | Phase 1 / Phase 2 | Not yet recruiting | Mansoura University | 80 | 2025-04-15 | 2025-04-01 |
| Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE) Pravastatin, Pentoxifylline, Tocopherol - Lymphedema, Fibrosis | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 295 | 2025-02-13 | 2026-09-11 |
| Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial Metformin Hydrochloride, betamethasone dipropionate, Pentoxifylline - Oral Submucous Fibrosis | Phase 1 / Phase 2 | Completed | Ziauddin University | 30 | 2024-08-12 | 2025-05-02 |
| Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke Pentoxifylline - Cognitive Impairment | Phase 1 / Phase 2 | Unknown | The First Hospital of Hebei Medical University | 200 | 2024-04-10 | 2024-04-03 |
| Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers Topical Pentoxifylline Gel (Vehicle +PTX), Topical Placebo Gel (Vehicle) - Behcet Syndrome, Behcet Disease | Phase 2 | Unknown | Silk Road Therapies, Inc. | 60 | 2024-02-01 | 2023-08-03 |
| Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer Pentoxifylline 400mg plus chemotherapy, Chemotherapy - Breast Cancer Female, Breast Cancer Patients | Phase 2 | Completed | Mansoura University | 100 | 2023-12-25 | 2025-07-28 |
| Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients" Pentoxifylline Oral Tablet, Placebo - Breast Cancer Female | Phase 2 | Unknown | Mansoura University | 70 | 2023-12-15 | 2024-03-15 |
| The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery Pentoxifylline, paracetamol +ketorolac - Post-Surgical Complication, Breast Cancer Surgery | Phase 2 | Completed | Mansoura University | 92 | 2023-10-30 | 2025-06-26 |
| Role of Pentoxifylline and Celecoxib in Parkinsonism carbidopa-levodopa, Pentoxifylline 400 MG, Celecoxib 200mg - Parkinson Disease | Phase 2 | Completed | Mostafa Bahaa | 80 | 2023-08-07 | 2025-08-12 |
| Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib - Diabetic Kidney Disease | Phase 2 | Terminated | Iain Bressendorff | 1 | 2023-08-01 | 2024-09-25 |
| Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes tadalafil, Sildenafil, pentoxifylline - IVF | Phase 2 / Phase 3 | Unknown | Beni-Suef University | 200 | 2023-07-30 | 2023-08-03 |
| Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet - Sexually Transmitted Diseases | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 100 | 2023-06-20 | 2023-06-12 |
| RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Ibudilast, Pentoxifylline, Placebo - Long COVID, Post COVID Condition | Phase 2 / Phase 3 | Completed | University Health Network, Toronto | 460 | 2023-05-31 | 2026-02-23 |
| Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. Pentoxifylline 400 MG - Inflammatory Bowel Diseases | Phase 2 | Completed | Tanta University | 60 | 2023-02-02 | 2026-09-17 |
Showing 20 of 69. Sign in to see all of them.
Breast Neoplasms (7) · Fibrosis (6) · Cardiovascular Diseases (3) · Inflammation (3) · Inflammatory Bowel Diseases (3) · Lymphedema (3) · Atherosclerosis (2) · Depressive Disorder, Major (2) · Diabetic Nephropathies (2) · Fatty Liver (2) · Head and Neck Neoplasms (2) · Kidney Failure, Chronic (2) · Leishmaniasis (2) · Leishmaniasis, Cutaneous (2) · Muscular Dystrophy, Duchenne (2)
Tanta University (7) · Ain Shams University (4) · Mansoura University (4) · University Health Network, Toronto (4) · Indiana University (3) · M.D. Anderson Cancer Center (3) · Cooperative International Neuromuscular Research Group (2) · Hawler Medical University (2) · Mostafa Bahaa (2) · Royal Marsden NHS Foundation Trust (2) · Sadat City University (2) · Shaare Zedek Medical Center (2) · Taipei Medical University Hospital (2) · University of Brasilia (2) · Baylor College of Medicine (1)
United States (21) · Egypt (19) · Canada (5) · Israel (4) · Brazil (3) · Iran (2) · Iraq (2) · United Kingdom (2) · Argentina (1) · Australia (1) · China (1) · Colombia (1) · Denmark (1) · Germany (1) · Italy (1)
Cathy Hammerman, MD (2) · Diana Escolar, MD (2) · Samir K. Gupta, MD, MS (2) · Talar A Merzamohammad, Pharm. D (2) · Wilfred Levin, MD (2) · Alexandra Taylor (1) · Amin Banihashemi (1) · Andew J Sulich, MD (1) · Angela M Cheung, MD,PhD (1) · Arthur J McCullough, MD (1) · Asmaa Saeed, Bachelor (1) · Atef Taha, M.D (1) · Chad Tang (1) · Claudia O Zein, MD, MSc (1) · Claudia O. Zein, MD, MSc (1)
PMID 11675328, PMID 15542159, PMID 16155013, PMID 16322159, PMID 17366834, PMID 18358930, PMID 21220611, PMID 21677329, PMID 21748765, PMID 21846410, PMID 21943236, PMID 22037714, PMID 22074157, PMID 22086414, PMID 22265847, PMID 22323480, PMID 23140366, PMID 23244073, PMID 23593327, PMID 25393877, PMID 28379954, PMID 28390753, PMID 31472446, PMID 31748905, PMID 31811953, PMID 33008091, PMID 34007848, PMID 35084335, PMID 35093409, PMID 35340032, PMID 35410255, PMID 36341700, PMID 36552855, PMID 37011138, PMID 38817362, PMID 39192162, PMID 39340691, PMID 39421449, PMID 40253769, PMID 40393653, PMID 40739381, PMID 40741002, PMID 41164763, PMID 8618179
R01HL095149 (2), 2008 (1), R24MH080827 (1), U01AA021893 (1)